Headline
The latest stories from AHA Today.
The Substance Abuse and Mental Health Services Administration will host a July 10 webinar.
The Centers for Medicare & Medicaid Services has extended the deadline for submitting signed participation agreements and selecting clinical episodes for the Bundled Payments for Care Improvement Advanced model by one week to Aug. 8, and the due date for program deliverables to Sept. 14.
The Centers for Medicare & Medicaid Services yesterday released the home health prospective payment system proposed rule for calendar year 2019, which also proposes a major redesign for CY 2020.
Attorney General Jeff Sessions yesterday named as acting administrator of the Drug Enforcement Administration Uttam Dhillon, a past director of the Office of Counternarcotics Enforcement at the Department of Homeland Security who recently served as deputy counsel and deputy assistant to the鈥
The AHA Physician Alliance July 10 at 3:30 p.m. ET will host a webinar featuring Chris Moriates, M.D., a hospital medicine physician and assistant dean for health care value at Dell Medical School at The University of Texas at Austin.
More than 10.6 million individuals had paid their first month鈥檚 premium to officially trigger their 2018 health insurance coverage through the federal and state-based exchanges in February.
A federal judge Friday voided the Department of Health and Human Services鈥 approval of a Kentucky Medicaid demonstration waiver that would require some adult beneficiaries to work or participate in other 鈥渃ommunity engagement鈥 activities.
A new tool supported by the National Institutes of Health uses education, housing and poverty measures to rank and map neighborhoods according to socioeconomic disadvantage.
The AHA, in partnership with the American Board of Internal Medicine's Choosing Wisely campaign and the Costs of Care organization, is enrolling clinical teams in a 12-month virtual High-Value Care Collaborative.
Congress and the administration should pursue actions, including addressing the high costs of prescription drugs and regulatory burden on providers, that will help reduce the cost of care without putting access at risk.